- Corporate Officers - F
- Foletta Mark G
Insider Trading History of Foletta Mark G
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Foletta Mark G since 2015.
This trader's CIK number is 1236389.
At the time of last reporting, Foletta Mark G was the Director of Dexcom Inc. (stock ticker symbol DXCM).
Also see all insider trading activities at Dexcom Inc.
Note that in the past
FOLETTA MARK G also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Amn Healthcare Services Inc (AMN) by Foletta Mark G
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | AMN | 0 | $0 | 0 | $0 | 3,019 | $0 |
| 2024 | AMN | 0 | $0 | 0 | $0 | 1,681 | $0 |
| 2023 | AMN | 0 | $0 | 7,500 | $639,748 | 1,458 | $0 |
| 2022 | AMN | 0 | $0 | 0 | $0 | 2,139 | $0 |
| 2021 | AMN | 0 | $0 | 2,500 | $237,540 | 2,826 | $0 |
| 2020 | AMN | 0 | $0 | 0 | $0 | 2,907 | $0 |
| 2019 | AMN | 0 | $0 | 0 | $0 | 2,153 | $0 |
| 2018 | AMN | 0 | $0 | 0 | $0 | 3,365 | $0 |
| 2017 | AMN | 0 | $0 | 4,000 | $172,632 | 3,793 | $0 |
| 2016 | AMN | 0 | $0 | 1,800 | $68,058 | 5,532 | $0 |
Yearly summary of insider trading at Dexcom Inc (DXCM) by Foletta Mark G
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | DXCM | 0 | $0 | 13,750 | $1,158,312 | 0 | $0 |
| 2024 | DXCM | 0 | $0 | 6,000 | $701,192 | 0 | $0 |
| 2021 | DXCM | 0 | $0 | 1,500 | $866,293 | 0 | $0 |
| 2020 | DXCM | 0 | $0 | 6,000 | $1,863,970 | 0 | $0 |
| 2019 | DXCM | 0 | $0 | 5,000 | $763,979 | 0 | $0 |
| 2018 | DXCM | 0 | $0 | 1,000 | $137,503 | 0 | $0 |
| 2017 | DXCM | 0 | $0 | 2,500 | $137,385 | 0 | $0 |
| 2016 | DXCM | 0 | $0 | 1,800 | $170,325 | 0 | $0 |
Yearly summary of insider trading at Regulus Therapeutics Inc. (RGLS) by Foletta Mark G
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | RGLS | 10,000 | $76,410 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Forte Biosciences, Inc. (TOCA) by Foletta Mark G
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | TOCA | 5,000 | $21,475 | 0 | $0 | 0 | $0 |
| 2017 | TOCA | 5,000 | $50,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Foletta Mark G:
1. Amn Healthcare Services Inc (AMN)
2. Dexcom Inc (DXCM)
3. Regulus Therapeutics Inc. (RGLS)
4. Forte Biosciences, Inc. (TOCA)
Table 1. Insider trading of Amn Healthcare Services Inc (AMN) by Foletta Mark G
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-04-19 | AMN | Option Ex | 3,019 | .00 | 0 |
| 2024-04-19 | AMN | Option Ex | 1,681 | .00 | 0 |
| 2023-04-21 | AMN | Sale | 1,458 | 88.78 | 129,441 |
| 2023-04-21 | AMN | Option Ex | 1,458 | .00 | 0 |
| 2023-04-11 | AMN | Sale | 6,042 | 84.46 | 510,307 |
| 2022-04-21 | AMN | Option Ex | 2,139 | .00 | 0 |
| 2021-06-11 | AMN | Sale | 2,500 | 95.02 | 237,540 |
| 2021-04-21 | AMN | Option Ex | 2,826 | .00 | 0 |
| 2020-04-17 | AMN | Option Ex | 2,907 | .00 | 0 |
| 2019-04-17 | AMN | Option Ex | 2,153 | .00 | 0 |
| 2018-04-18 | AMN | Option Ex | 3,365 | .00 | 0 |
| 2017-11-27 | AMN | Sale | 2,500 | 47.03 | 117,575 |
| 2017-06-13 | AMN | Sale | 1,500 | 36.70 | 55,057 |
| 2017-04-19 | AMN | Option Ex | 3,793 | .00 | 0 |
| 2016-12-15 | AMN | Sale | 1,800 | 37.81 | 68,058 |
| 2016-04-20 | AHS | Option Ex | 5,532 | .00 | 0 |
Table 2. Insider trading of Dexcom Inc (DXCM) by Foletta Mark G
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-08-15 | DXCM | Sale | 2,750 | 81.28 | 223,517 |
| 2025-07-15 | DXCM | Sale | 2,750 | 85.60 | 235,397 |
| 2025-07-15 | DXCM | Sale | 2,750 | 85.60 | 235,397 |
| 2025-07-15 | DXCM | Sale | 2,750 | 85.60 | 235,397 |
| 2025-06-16 | DXCM | Sale | 2,750 | 83.13 | 228,604 |
| 2024-06-17 | DXCM | Sale | 2,694 | 116.70 | 314,400 |
| 2024-06-18 | DXCM | Sale | 3,306 | 117.00 | 386,792 |
| 2021-12-01 | DXCM | Sale | 500 | 563.37 | 281,684 |
| 2021-11-01 | DXCM | Sale | 500 | 625.76 | 312,879 |
| 2021-10-01 | DXCM | Sale | 500 | 543.46 | 271,730 |
| 2020-11-16 | DXCM | Sale | 1,000 | 339.94 | 339,942 |
| 2020-10-15 | DXCM | Sale | 1,000 | 395.73 | 395,734 |
| 2020-09-14 | DXCM | Sale | 1,000 | 393.13 | 393,135 |
| 2020-03-03 | DXCM | Sale | 1,000 | 278.24 | 278,239 |
| 2020-02-03 | DXCM | Sale | 1,000 | 238.61 | 238,606 |
| 2020-01-03 | DXCM | Sale | 1,000 | 218.31 | 218,314 |
| 2019-12-03 | DXCM | Sale | 1,000 | 225.51 | 225,509 |
| 2019-05-15 | DXCM | Sale | 1,000 | 121.08 | 121,085 |
| 2019-04-15 | DXCM | Sale | 1,000 | 118.40 | 118,401 |
| 2019-03-15 | DXCM | Sale | 1,000 | 149.96 | 149,962 |
| 2019-02-15 | DXCM | Sale | 1,000 | 149.02 | 149,022 |
| 2018-08-24 | DXCM | Sale | 1,000 | 137.50 | 137,503 |
| 2017-11-27 | DXCM | Sale | 2,500 | 54.95 | 137,385 |
| 2016-09-07 | DXCM | Sale | 1,800 | 94.62 | 170,325 |
Table 3. Insider trading of Regulus Therapeutics Inc. (RGLS) by Foletta Mark G
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-08-13 | RGLS | Buy | 10,000 | 7.64 | 76,410 |
Table 4. Insider trading of Forte Biosciences, Inc. (TOCA) by Foletta Mark G
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-05-28 | TOCA | Buy | 5,000 | 4.29 | 21,475 |
| 2017-04-19 | TOCA | Buy | 5,000 | 10.00 | 50,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Foletta Mark G
(Director of Dexcom Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.